
Thermo Fisher Scientific TMO
$ 475.66
-1.32%
Annual report 2025
added 02-26-2026
Thermo Fisher Scientific EBITDA per Share 2011-2026 | TMO
Annual EBITDA per Share Thermo Fisher Scientific
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 23.3 | 22.2 | 20.5 | 23.9 | 27.6 | 21.3 | 14.7 | 13.9 | 11.8 | 10.2 | 9.45 | 8.13 | 6.8 | 6.35 | 5.24 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 27.6 | 5.24 | 15 |
Quarterly EBITDA per Share Thermo Fisher Scientific
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.74 | 5.53 | 5.27 | 5.57 | 5.49 | 5.1 | - | - | 4.7 | - | 6.22 | 5.1 | 7.83 | - | 7.34 | 5.5 | 8.24 | - | 7.31 | 4.3 | 2.66 | - | 3.4 | 4.43 | 2.63 | - | 2.6 | 2.65 | 3.39 | - | 5.29 | 4.34 | 2.77 | - | 4.62 | 3.78 | 2.36 | - | 4.58 | 3.59 | 2.27 | - | 4.74 | 2.88 | 3.16 | - | 3.16 | 2.43 | 1.78 | - | 2.98 | 2.32 | 1.64 | - | 2.45 | 1.7 | 1.3 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 8.24 | 1.3 | 4.07 |
EBITDA per Share of other stocks in the Diagnostics research industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
-218 | - | -8.98 % | $ 14.8 K | ||
|
Centogene N.V.
CNTG
|
-0.94 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
-0.61 | - | - | $ 1.31 B | ||
|
Quest Diagnostics Incorporated
DGX
|
19.1 | $ 203.83 | 0.02 % | $ 22.6 B | ||
|
Celcuity
CELC
|
-3.68 | $ 89.49 | 1.42 % | $ 4.18 B | ||
|
Akumin
AKU
|
0.78 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
-36.9 | $ 4.7 | -3.69 % | $ 6.25 M | ||
|
Fulgent Genetics
FLGT
|
-2.18 | $ 18.78 | -0.79 % | $ 578 M | ||
|
Castle Biosciences
CSTL
|
-0.07 | $ 21.01 | -0.33 % | $ 609 M | ||
|
Aspira Women's Health
AWH
|
-0.23 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-1.46 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-1.79 | - | -13.05 % | $ 7.29 M | ||
|
ICON Public Limited Company
ICLR
|
10.5 | $ 149.92 | 3.69 % | $ 11.8 B | ||
|
Illumina
ILMN
|
6.95 | $ 166.21 | 2.3 % | $ 25.8 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
0.00122 | - | - | $ 562 M | ||
|
Guardant Health
GH
|
-3.17 | $ 130.9 | 0.15 % | $ 16.4 B | ||
|
CareDx, Inc
CDNA
|
-0.3 | $ 23.66 | 0.85 % | $ 1.26 B | ||
|
Chembio Diagnostics
CEMI
|
-0.65 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.38 | - | - | $ 9.42 M | ||
|
Interpace Biosciences
IDXG
|
1.02 | $ 1.65 | -6.41 % | $ 7.3 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-22.8 | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
5.37 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
-1.27 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-1.51 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-3.17 | - | -11.32 % | $ 2.94 M | ||
|
Lantheus Holdings
LNTH
|
5.64 | $ 104.32 | 4.07 % | $ 7.04 B | ||
|
Pacific Biosciences of California
PACB
|
-1.8 | $ 1.35 | -1.46 % | $ 405 M | ||
|
Charles River Laboratories International
CRL
|
8.64 | $ 188.06 | 0.95 % | $ 9.32 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
8.68 | - | - | $ 10.7 B | ||
|
Medpace Holdings
MEDP
|
19.5 | $ 475.07 | 2.01 % | $ 13.7 B | ||
|
Exact Sciences Corporation
EXAS
|
-0.43 | - | - | $ 19.8 B | ||
|
Mettler-Toledo International
MTD
|
2.48 | $ 1 141.25 | 0.73 % | $ 23.5 B | ||
|
NeoGenomics
NEO
|
-0.62 | $ 11.47 | 1.68 % | $ 1.47 B | ||
|
Myriad Genetics
MYGN
|
-3.6 | $ 4.63 | 4.51 % | $ 429 M | ||
|
National Research Corporation
NRC
|
1.35 | $ 18.79 | -11.7 % | $ 421 M | ||
|
Natera
NTRA
|
-1.96 | $ 219.23 | 1.26 % | $ 30 B | ||
|
Personalis
PSNL
|
-0.87 | $ 9.42 | -1.98 % | $ 841 M | ||
|
Koninklijke Philips N.V.
PHG
|
2.69 | $ 26.11 | 1.71 % | $ 24.8 B | ||
|
Senseonics Holdings
SENS
|
-1.6 | $ 7.33 | 0.41 % | $ 306 M | ||
|
Twist Bioscience Corporation
TWST
|
-1.86 | $ 74.05 | 9.27 % | $ 4.43 B | ||
|
QIAGEN N.V.
QGEN
|
3.04 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
0.22 | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
-2.2 | $ 2.09 | 3.47 % | $ 4.8 M | ||
|
Laboratory Corporation of America Holdings
LH
|
24.8 | $ 265.27 | -1.26 % | $ 22.1 B | ||
|
Trinity Biotech plc
TRIB
|
-0.06 | $ 0.68 | -1.82 % | $ 244 M | ||
|
Motus GI Holdings
MOTS
|
-7.41 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
-4.34 | $ 9.24 | 0.82 % | $ 2 B | ||
|
Invitae Corporation
NVTA
|
0.2 | - | - | $ 21.2 M |